Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Pharming Group N.V. is a specialized biopharmaceutical company based in the Netherlands. It focuses on the development and commercialization of innovative protein therapeutics for rare diseases. The company improves the quality of life for patients through the delivery of specialized, life-changing medicine.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Pharming is scheduled to report its next quarterly earnings on 11/05/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Pharming last reported quarterly earnings on 7/30/2026 (Q2 2026). Earnings per share (EPS) came in at 0.00 EUR.
Across its last 3 earnings reports, Pharming stock moved by ±16.5% on average the following day. The largest reaction was -25.8% on 05/07/2026; 0 of 3 reactions were positive.
Pharming has beaten analyst EPS estimates in 1 of its last 3 evaluated quarters (beat rate: 33.3%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 3 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.